ACS:180 AND ADVIA CENTAUR B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAYS— 510(k) K040425

Substantially Equivalent

Bayer Healthcare, LLC

FDA 510(k) clearance K040425 for ACS:180 AND ADVIA CENTAUR B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAYS, Substantially Equivalent on 2004-06-14. Applicant: Bayer Healthcare, LLC.

Clearance details

Applicant: Bayer Healthcare, LLC
Product code: Code NBC
Advisory panel: Clinical Chemistry
Date received: 2004-02-18
Decision date: 2004-06-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.